TWI427148B - 用於生產l-天冬醯胺酶ii的重組宿主 - Google Patents

用於生產l-天冬醯胺酶ii的重組宿主 Download PDF

Info

Publication number
TWI427148B
TWI427148B TW096123026A TW96123026A TWI427148B TW I427148 B TWI427148 B TW I427148B TW 096123026 A TW096123026 A TW 096123026A TW 96123026 A TW96123026 A TW 96123026A TW I427148 B TWI427148 B TW I427148B
Authority
TW
Taiwan
Prior art keywords
aspartate
enzyme
recombinant
seq
host cell
Prior art date
Application number
TW096123026A
Other languages
English (en)
Chinese (zh)
Other versions
TW200817518A (en
Inventor
David Ray Filpula
Maoliang Wang
Original Assignee
Sigma Tau Rare Diseases S A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Rare Diseases S A filed Critical Sigma Tau Rare Diseases S A
Publication of TW200817518A publication Critical patent/TW200817518A/zh
Application granted granted Critical
Publication of TWI427148B publication Critical patent/TWI427148B/zh

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/78Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5)
    • C12N9/80Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5) acting on amide bonds in linear amides (3.5.1)
    • C12N9/82Asparaginase (3.5.1.1)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/96Stabilising an enzyme by forming an adduct or a composition; Forming enzyme conjugates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
TW096123026A 2006-06-30 2007-06-26 用於生產l-天冬醯胺酶ii的重組宿主 TWI427148B (zh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US81781706P 2006-06-30 2006-06-30

Publications (2)

Publication Number Publication Date
TW200817518A TW200817518A (en) 2008-04-16
TWI427148B true TWI427148B (zh) 2014-02-21

Family

ID=38957454

Family Applications (1)

Application Number Title Priority Date Filing Date
TW096123026A TWI427148B (zh) 2006-06-30 2007-06-26 用於生產l-天冬醯胺酶ii的重組宿主

Country Status (17)

Country Link
US (2) US7807436B2 (https=)
EP (1) EP2046369B1 (https=)
JP (1) JP5308333B2 (https=)
KR (1) KR101408062B1 (https=)
CN (1) CN101484181B (https=)
AU (1) AU2007275535B2 (https=)
CA (1) CA2652718A1 (https=)
DK (1) DK2046369T3 (https=)
ES (1) ES2553329T3 (https=)
HU (1) HUE025738T2 (https=)
IL (1) IL195168A (https=)
MX (1) MX2009000284A (https=)
NZ (1) NZ572519A (https=)
PL (1) PL2046369T3 (https=)
PT (1) PT2046369E (https=)
TW (1) TWI427148B (https=)
WO (1) WO2008011234A2 (https=)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR102014000585B1 (pt) 2014-01-10 2021-01-12 Coppe/Ufrj-Instituto Alberto Luiz Coimbra De Pós-Graduação l-asparaginase recombinante de zymomonas
CN105802948B (zh) 2014-12-29 2020-06-09 江苏众红生物工程创药研究院有限公司 聚乙二醇定点修饰的门冬酰胺酶及其制备方法与应用
US10480014B2 (en) * 2015-06-15 2019-11-19 Ajou University Industry-Academic Cooperation Foundation Method for producing natural rubber by using recombinant microorganism
KR102783452B1 (ko) 2016-06-01 2025-03-19 세르비에 아이피 유케이 리미티드 폴리알킬렌 옥시드-아스파라기나제의 제형, 및 그의 제조 및 사용 방법
KR101837636B1 (ko) * 2016-06-14 2018-03-12 전남대학교산학협력단 코리네박테리움 재조합 균주를 이용한 아스파라기나제의 분비생산 방법
CN108795832B (zh) * 2017-04-26 2021-05-14 江苏恒瑞医药股份有限公司 一种内源l-门冬酰胺酶ii基因敲除的宿主菌、其制备方法及其应用
WO2019083794A1 (en) 2017-10-27 2019-05-02 Pfenex Inc. PROCESS FOR PRODUCING EAR ASPARAGINASE. RECOMBINED COLI
JP7784804B2 (ja) 2017-10-27 2025-12-12 フェネックス インク. 組み換えerwiniaアスパラギナーゼの製造のための方法
US11364223B2 (en) 2018-12-13 2022-06-21 Huyabio International, Llc Sulcardine administration for treatment of acute atrial fibrillation
US20220227805A1 (en) 2020-12-23 2022-07-21 Jazz Pharmaceuticals Ireland Ltd. Methods of purifying charge-shielded fusion proteins
CN114854729B (zh) * 2021-02-03 2025-09-02 重庆派金生物科技有限公司 定向化学偶联门冬酰胺酶突变体及其制备方法和应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5324844A (en) 1989-04-19 1994-06-28 Enzon, Inc. Active carbonates of polyalkylene oxides for modification of polypeptides
US5122614A (en) 1989-04-19 1992-06-16 Enzon, Inc. Active carbonates of polyalkylene oxides for modification of polypeptides
US5643575A (en) 1993-10-27 1997-07-01 Enzon, Inc. Non-antigenic branched polymer conjugates
US5919455A (en) 1993-10-27 1999-07-06 Enzon, Inc. Non-antigenic branched polymer conjugates
US5615460A (en) * 1994-06-06 1997-04-01 The Procter & Gamble Company Female component for refastenable fastening device having regions of differential extensibility
US6180095B1 (en) 1997-12-17 2001-01-30 Enzon, Inc. Polymeric prodrugs of amino- and hydroxyl-containing bioactive agents
US5965119A (en) 1997-12-30 1999-10-12 Enzon, Inc. Trialkyl-lock-facilitated polymeric prodrugs of amino-containing bioactive agents
US6958212B1 (en) 1999-02-01 2005-10-25 Eidgenossische Technische Hochschule Zurich Conjugate addition reactions for the controlled delivery of pharmaceutically active compounds
US7087229B2 (en) 2003-05-30 2006-08-08 Enzon Pharmaceuticals, Inc. Releasable polymeric conjugates based on aliphatic biodegradable linkers
US7122189B2 (en) 2002-08-13 2006-10-17 Enzon, Inc. Releasable polymeric conjugates based on aliphatic biodegradable linkers
CN100502944C (zh) * 2005-09-16 2009-06-24 北京双鹭药业股份有限公司 一种天门冬酰胺酶注射液、其制备方法及应用

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Wang Y et al., "Cloning and expression of L-asparaginase gene in Escherichia coli.", Appl Biochem Biotechnol. 2001 Aug;95(2):93-101. MERK & CO.,INC.,"ELSPAR® (asparaginase)", Aug 2000. Pinheiro et al., "Serum asparaginase activities and asparagine concent *

Also Published As

Publication number Publication date
HUE025738T2 (en) 2016-04-28
KR20090033175A (ko) 2009-04-01
MX2009000284A (es) 2009-01-26
CN101484181A (zh) 2009-07-15
WO2008011234A2 (en) 2008-01-24
ES2553329T3 (es) 2015-12-07
TW200817518A (en) 2008-04-16
IL195168A (en) 2014-12-31
PT2046369E (pt) 2015-11-26
KR101408062B1 (ko) 2014-06-20
JP5308333B2 (ja) 2013-10-09
US7807436B2 (en) 2010-10-05
EP2046369A4 (en) 2010-04-21
US20080063632A1 (en) 2008-03-13
CA2652718A1 (en) 2008-01-24
NZ572519A (en) 2011-06-30
DK2046369T3 (en) 2015-11-30
AU2007275535B2 (en) 2012-08-16
CN101484181B (zh) 2012-12-26
AU2007275535A1 (en) 2008-01-24
JP2009542219A (ja) 2009-12-03
IL195168A0 (en) 2011-08-01
US20100273236A1 (en) 2010-10-28
EP2046369A2 (en) 2009-04-15
PL2046369T3 (pl) 2016-01-29
WO2008011234A3 (en) 2008-10-16
EP2046369B1 (en) 2015-08-12

Similar Documents

Publication Publication Date Title
TWI427148B (zh) 用於生產l-天冬醯胺酶ii的重組宿主
JP4126097B2 (ja) Mycoplasma arthritidis由来アルギニンデイミナーゼ及びそれを含むポリマーコンジュゲート
JP4903891B2 (ja) シアノビリン変異体−ポリマー接合体
JP2010500963A (ja) 安定化タンパク質
US8715929B2 (en) Synthetic operon
US20040180348A1 (en) Method for surface display of proteins of genetic carriers
US11060123B2 (en) Production of soluble recombinant protein without n-terminal methionine
CN115867578A (zh) 利用大肠杆菌生产全长抗体的方法
US20250302993A1 (en) Enzyme, complex, recombinant vector, therapeutic agent for genetic disorder, and polynucleotide
JP2023139192A (ja) Crm197タンパク質発現方法
RU2803949C1 (ru) Способ экспрессии белка crm197
US12104161B2 (en) Production of soluble recombinant proteins without N-terminal methionine in E-coli

Legal Events

Date Code Title Description
MM4A Annulment or lapse of patent due to non-payment of fees